Yuan Cheng

1.8k total citations
100 papers, 1.3k citations indexed

About

Yuan Cheng is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Yuan Cheng has authored 100 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Molecular Biology and 25 papers in Obstetrics and Gynecology. Recurrent topics in Yuan Cheng's work include Endometrial and Cervical Cancer Treatments (25 papers), Cancer-related molecular mechanisms research (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Yuan Cheng is often cited by papers focused on Endometrial and Cervical Cancer Treatments (25 papers), Cancer-related molecular mechanisms research (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Yuan Cheng collaborates with scholars based in China, United States and Japan. Yuan Cheng's co-authors include Jianliu Wang, Yangyang Dong, Jingyi Zhou, Xiao Yang, Lijun Zhao, Xingchen Li, Xiaoping Li, Zhiqi Wang, Li Geng and Youyi Zhang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Cancer Research.

In The Last Decade

Yuan Cheng

95 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Cheng China 18 513 298 291 161 147 100 1.3k
Xingsheng Yang China 27 800 1.6× 409 1.4× 412 1.4× 325 2.0× 160 1.1× 95 1.8k
Kitty Pavlakis Greece 23 576 1.1× 510 1.7× 346 1.2× 223 1.4× 299 2.0× 80 1.6k
Christina Körbel Germany 19 630 1.2× 264 0.9× 234 0.8× 140 0.9× 90 0.6× 39 1.3k
Ké Li China 22 785 1.5× 357 1.2× 251 0.9× 73 0.5× 125 0.9× 96 1.5k
Yuan Fan China 17 444 0.9× 211 0.7× 248 0.9× 117 0.7× 87 0.6× 39 1.2k
Hervé Sartelet France 23 807 1.6× 527 1.8× 377 1.3× 46 0.3× 224 1.5× 82 1.7k
Qin Yang China 20 760 1.5× 182 0.6× 415 1.4× 37 0.2× 126 0.9× 61 1.5k
Valeria Lucchini Italy 21 548 1.1× 269 0.9× 123 0.4× 84 0.5× 64 0.4× 36 1.3k
Wenfeng Cao China 22 947 1.8× 396 1.3× 456 1.6× 42 0.3× 225 1.5× 59 1.6k
Hong Shu China 22 780 1.5× 245 0.8× 309 1.1× 27 0.2× 177 1.2× 94 1.4k

Countries citing papers authored by Yuan Cheng

Since Specialization
Citations

This map shows the geographic impact of Yuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Cheng more than expected).

Fields of papers citing papers by Yuan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Cheng. The network helps show where Yuan Cheng may publish in the future.

Co-authorship network of co-authors of Yuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Cheng. A scholar is included among the top collaborators of Yuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Cheng. Yuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
4.
Wang, Li, Jianfeng Zhang, Zhen Meng, et al.. (2024). Recovery of lithium from high Mg2+/Li+ ratio brine using a novel solvent extraction system TOP-FeCl3-MIBK. Desalination. 599. 118445–118445. 5 indexed citations
5.
6.
Jiang, Wenyan, Yuan Cheng, Haotian Wang, et al.. (2023). Intra‐ and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer. Journal of Magnetic Resonance Imaging. 59(2). 613–625. 25 indexed citations
7.
Li, Xingchen, et al.. (2023). Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients. Journal of Gynecologic Oncology. 34(6). e69–e69. 4 indexed citations
8.
Yang, Xiao, Yuan Cheng, Jingyi Zhou, et al.. (2022). Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes. Advanced Science. 9(8). e2104472–e2104472. 31 indexed citations
9.
Yang, Xiao, Xingchen Li, Yuan Cheng, et al.. (2022). Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer. Frontiers in Cell and Developmental Biology. 9. 797826–797826. 14 indexed citations
10.
Cheng, Yuan, Xingchen Li, Yibo Dai, et al.. (2021). Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer. Journal of Gynecologic Oncology. 32(3). e30–e30. 11 indexed citations
11.
Yang, Xiao, Xingchen Li, Yangyang Dong, et al.. (2021). Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer. Frontiers in Endocrinology. 12. 780769–780769. 37 indexed citations
12.
Cheng, Yuan, Yangyang Dong, Wenjuan Tian, et al.. (2020). Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation. Journal of Oncology. 2020. 1–11. 5 indexed citations
13.
Dong, Yangyang, et al.. (2019). Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center. Journal of Gynecologic Oncology. 31(3). e27–e27. 10 indexed citations
14.
Cheng, Yuan, Lu Xu, Min Sun, et al.. (2019). Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.. PubMed. 22(4). 1004–1010. 9 indexed citations
15.
Li, Mingxia, Xiaoping Li, Lijun Zhao, et al.. (2018). Human omental adipose‐derived stem cells from donors with different body mass index had similar effects on proliferation and migration of endometrial cancer cells in vitro. Journal of obstetrics and gynaecology research. 45(2). 417–427. 3 indexed citations
16.
Cheng, Yuan, Le Wang, Min Sun, et al.. (2018). Which neoadjuvant chemotherapy regimen should be recommended for patients with advanced nasopharyngeal carcinoma?. Medicine. 97(34). e11978–e11978. 14 indexed citations
17.
Cheng, Yuan, et al.. (2015). Predictive value of MGMT promoter methylation status in Asian and Caucasian patients with malignant gliomas: a meta-analysis.. PubMed. 8(4). 6553–62. 1 indexed citations
18.
Bai, Fang, et al.. (2006). Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. International Journal of Gynecological Cancer. 16(1). 202–209. 19 indexed citations
19.
Rabenau, Karen E., Dan Lu, Paul Balderes, et al.. (2006). Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Research. 66(18). 9162–9170. 105 indexed citations
20.
Zhang, X., et al.. (2005). Characterization of differentially expressed genes in ovarian cancer by cDNA microarrays. International Journal of Gynecological Cancer. 15(1). 50–57. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026